[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,196,896
  • Shares Outstanding, K 132,600
  • Annual Sales, $ 982,020 K
  • Annual Income, $ -416,280 K
  • EBIT $ -448 M
  • EBITDA $ -414 M
  • 60-Month Beta 1.48
  • Price/Sales 17.99
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 53.88% (-0.79%)
  • Historical Volatility 60.29%
  • IV Percentile 11%
  • IV Rank 17.64%
  • IV High 83.67% on 04/30/26
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 19) 11.28 (8.70%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 938
  • Volume Avg (30-Day) 1,142
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 16,355
  • Open Int (30-Day) 20,895
  • Expected Range 118.41 to 140.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.74
  • Number of Estimates 3
  • High Estimate $-0.70
  • Low Estimate $-0.76
  • Prior Year $-0.79
  • Growth Rate Est. (year over year) +6.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.01 +64.14%
on 04/30/26
133.97 -3.19%
on 05/29/26
+46.28 (+55.48%)
since 04/29/26
3-Month
74.55 +73.96%
on 04/10/26
133.97 -3.19%
on 05/29/26
+35.79 (+38.12%)
since 02/27/26
52-Week
38.03 +241.02%
on 05/29/25
133.97 -3.19%
on 05/29/26
+91.50 (+239.59%)
since 05/28/25

Most Recent Stories

More News
Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders

Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders

GH : 129.69 (-2.65%)
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

New performance data demonstrates validity of Guardant360 Liquid CDx as a comprehensive pan-cancer companion diagnostic Findings show how Guardant360...

GH : 129.69 (-2.65%)
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

Updated ACS guideline offers Shield as a new choice for over 50 million eligible Americans who are not up to date with their colorectal cancer screening ...

GH : 129.69 (-2.65%)
3 Growth Stocks We’re Skeptical Of

3 Growth Stocks We’re Skeptical Of

GH : 129.69 (-2.65%)
COLL : 33.61 (+0.72%)
GATX : 169.08 (-0.84%)
3 of Wall Street’s Favorite Stocks Walking a Fine Line

3 of Wall Street’s Favorite Stocks Walking a Fine Line

GH : 129.69 (-2.65%)
ACI : 15.61 (-1.95%)
PAHC : 30.79 (-3.27%)
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint

Guardant Health’s new FDA-approved liquid biopsy integrates genomic and epigenomic insights to provide a more complete, actionable view of cancer from a simple blood draw ...

GH : 129.69 (-2.65%)
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 21, 2026, the Compensation Committee of Guardant’s Board of Directors approved the granting of...

GH : 129.69 (-2.65%)
Why Guardant Health (GH) Stock Is Down Today

Why Guardant Health (GH) Stock Is Down Today

GH : 129.69 (-2.65%)
The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call

The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call

GH : 129.69 (-2.65%)
GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth

GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth

GH : 129.69 (-2.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 80%. The market has dropped from extreme overbought territory, indicating a possible trend reversal.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 138.66
2nd Resistance Point 136.32
1st Resistance Point 133.00
Last Price 129.69
1st Support Level 127.34
2nd Support Level 125.00
3rd Support Level 121.68

See More

52-Week High 133.97
Last Price 129.69
Fibonacci 61.8% 97.32
Fibonacci 50% 86.00
Fibonacci 38.2% 74.68
52-Week Low 38.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.